Zhejiang Shengda Bio-Pharm Co., Ltd. (SHA:603079)
China flag China · Delayed Price · Currency is CNY
13.61
+0.44 (3.34%)
Sep 30, 2026, 3:00 PM CST

SHA:603079 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
832.86844.54827.4727.41738.02789.73
Revenue Growth
-1.28%2.07%13.75%-1.44%-6.55%-8.95%
Gross Profit
206.36209.64163.674.18110.27216.33
Operating Income
55.1267.0731.54-54.48-10.0760.49
Net Income
44.8862.1629.42-54.0631.4875.76
Earnings Per Share
0.240.350.17-0.320.180.44
EPS Growth
-15.58%105.88%---59.09%-62.39%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024
Period EndingJun '26 Dec '25 Dec '24
Vitamins
231.38224.21244.71
Biological Preservatives and Functional Ingredients
505.44524.74489.31
External Steam Sales
18.4620.1837.19
Others
73.7171.5355.4
Sales Materials
-3.870.79
Total
832.86844.54827.4

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
626.35650.31345.63326.74330.72534.83
Total Debt
339.14324.86263.23239.242.65168.85
Net Cash (Debt)
287.22325.4582.487.54288.07365.98
Net Cash Growth
-294.95%-5.86%-69.61%-21.29%-18.70%
Net Cash Per Share
1.551.830.480.521.652.13

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
126.65138.88147.8864.4240.7274.46
Capital Expenditures
-125.68-145.68-169.85-245.93-63.26-99.96
Free Cash Flow
0.97-6.8-21.97-181.51-22.54-25.5
Free Cash Flow Growth
-90.05%-----

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
24.78%24.82%19.77%10.20%14.94%27.39%
Operating Margin
6.62%7.94%3.81%-7.49%-1.36%7.66%
Pretax Margin
7.41%9.49%5.93%-6.23%4.95%10.14%
Profit Margin
5.39%7.36%3.56%-7.43%4.27%9.59%
FCF Margin
0.12%-0.80%-2.66%-24.95%-3.05%-3.23%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.1000.100-0.0600.0600.140
Dividend Per Share Growth
0%--0%-57.14%-60.00%
Dividend Yield
0.73%0.57%-0.42%0.49%0.83%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
56.1053.3677.51-68.2439.09
Forward PE
-55.6055.6055.6055.6055.60
PS Ratio
3.063.932.763.422.913.75